- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01518686
Age-related Normative Values for the Octopus 900 Perimeter (Norm-Oct900)
Normal Values for the Full Visual Field, Corrected for Age- and Reaction Time, Using Semi-automated Kinetic Testing on the Octopus 900 Perimeter
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Baden-Württemberg
-
Tübingen, Baden-Württemberg, Germany, 72076
- Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- maximum spherical ametropia ± 6 Diopters (D)
- maximum cylindrical ametropia ± 2 D
- distant visual acuity ≥ 1.0 logMAR [20/20] for subjects up to 60 years, ≥ 0.8 logMAR [20/25] for subjects from 61-70 years, ≥ 0.63 logMAR [20/30] for subjects older than 70 years
- isocoria, pupil diameter > 3mm
- intraocular pressure (air pulse tonometer) ≤ 21mmHg
- normal anterior segments
- ocular fundus: normal appearance of the cup to disc ratio (CDR) ≤ 0.5, interocular difference of CDR < 0.3
- normal macular region, vessels, and peripheral retinal examination (with undilated pupils).
Exclusion Criteria:
- amblyopia
- strabismus
- ocular motility disorder
- diseases of the retina
- glaucoma, glaucoma suspect
- macular degeneration
- IOP > 21 mmHg
- abnormal color vision test (ISPP - Ishihara and Standard Pseudoisochromatic Plates = SPP)
- history or findings of other neuro-ophthalmological disease
- relevant opacities of the central refractive media (cornea, lens, vitreous body)
- use of miotic drugs
- intraocular surgery (except uncomplicated cataract surgery, more than three months previous to testing)
- kerato-refractive surgery (LASIK)
- drugs influencing reaction time
- drugs indicating severe general diseases (anti-diabetic pharmaceuticals and anti-hypertensive medication were allowed for subjects older than 70 years)
- mental diseases (for example psychosis)
- pregnancy, nursing
- acute infections
- heavy smoking (>10 cigarettes /day)
- alcohol abuse
- diabetic retinopathy
- coronary heart disease
- stroke
- migraine
- Raynaud's syndrome
- suspected lack of compliance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: one arm
observational study, no cohort, single group of different ages
|
We used the following six combinations of Goldmann8,1 stimulus size, stimulus luminance and angular velocity: V4e (64mm², 103', 320cd/m²) at 5°/s, III4e (4mm², 25.7', 320cd/m²) at 5°/s, I4e (0.25mm², 6.45', 320cd/m²) at 2°/s (for the assessment of the blind spot), I3e (0.25mm², 6.45', 100cd/m²) at 5°/s, I2e (0.25mm², 6.45', 32cd/m²) at 3°/s, I1e (0.25mm², 6.45', 10cd/m²) at 3°/s, I1a (0.25mm², 6.45', 4cd/m²) at 2°/s . The peripheral five isopters, consisting of 24 vectors (every 15° meridian), were presented in random order, while the innermost isopter (I1a) consisted of 12 vectors (every 30° meridian) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of the full Visual Field using semi-automated kinetic perimetry.
Time Frame: one day
|
additional a subgroup of 14 participants were tested at 3 separate sessions within 4 weeks.
|
one day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ulrich Schiefer, Prof. Dr. med., Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen, Germany
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 217/2006 local review board
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Octopus 900 perimeter (Haag Streit AG, Koeniz, Switzerland)
-
University of CatanzaroCompletedIntraocular Pressure | Central Corneal ThicknessItaly
-
University of ZurichUnknown